AbbVie's migraine drug meets main goal of late-stage study-February 2024-www.financetom.com

AbbVie's migraine drug meets main goal of late-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

AbbVie's migraine drug meets main goal of late-stage study

Jun 18, 2025 4:43 AM

June 18 (Reuters) - AbbVie ( ABBV ) said on Wednesday

its migraine drug met the main goal and was superior to a

generic drug in a head-to head late-stage trial.

Previous page： For Just Rs 119 a month, you can now get Spotify in India Next page： Samsung Galaxy S10, S10 Plus likely to have preinstalled plastic screen guard, says report

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

For Just Rs 119 a month, you can now get Spotify in India

Feb 26, 2019

Spotify, a music streaming service, is now available for download in India on the App Store, Google Play and Microsoft Store, reported Gadgets 360.

Samsung Galaxy S10, S10 Plus likely to have preinstalled plastic screen guard, says report

Mar 1, 2019

The report said this is similar to what OnePlus provides and said the screen guard is likely to scratch over time as it is only for a temporary basis.

Huawei plans billions in dividends for staff despite row with US

Mar 1, 2019

China's Huawei is set to reward employee shareholders with a 3 percent rise in cash dividends that are worth billions of dollars.

Full-frame mirrorless cameras to click our next India story, says Canon

Feb 28, 2019

On Wednesday, the company launched the lightest and smallest EOS RP in India, starting at Rs 110,495. With the EOS RP kit, the camera will cost Rs 199,490.